A role for islet neogenesis in curing diabetes

[1]  R. Calne.  Transplantation: current developments and future directions. , 2007, Reviews in the neurosciences.

[2]  S. Bonner-Weir,et al.  Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth , 2008, Proceedings of the National Academy of Sciences.

[3]  A. Fleming.  What Will It Take to Get Therapies Approved for Type 1 Diabetes? , 2008, Annals of the New York Academy of Sciences.

[4]  Douglas A. Melton,et al.  In vivo reprogramming of adult pancreatic exocrine cells to β-cells , 2008, Nature.

[5]  C. Ricordi,et al.  The Clinical Impact of Islet Transplantation , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  L. Rosenberg,et al.  Cellular origins of adult human islet in vitro dedifferentiation , 2008, Laboratory Investigation.

[7]  Yuebo Zhang,et al.  Differentiation of embryonic stem cells towards pancreatic progenitor cells and their transplantation into streptozotocin‐induced diabetic mice , 2008, Cell biology international.

[8]  W. Tamborlane,et al.  Sensor-augmented pump therapy in type 1 diabetes , 2008, Current opinion in endocrinology, diabetes, and obesity.

[9]  C. Ricordi,et al.  Toward a renewable source of pancreatic β-cells , 2008, Nature Biotechnology.

[10]  Z. Han,et al.  Mesenchymal stem cells: biology and clinical potential in type 1 diabetes therapy , 2008, Journal of cellular and molecular medicine.

[11]  E. Kroon,et al.  Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo , 2008, Nature Biotechnology.

[12]  R. Scharfmann,et al.  β Cells Can Be Generated from Endogenous Progenitors in Injured Adult Mouse Pancreas , 2008, Cell.

[13]  J. Leahy,et al.  Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas , 2008 .

[14]  J. Lakey,et al.  Combination therapy with glucagon-like peptide-1 and gastrin induces beta-cell neogenesis from pancreatic duct cells in human islets transplanted in immunodeficient diabetic mice. , 2008, Cell transplantation.

[15]  C. Ricordi,et al.  Transplantation: current developments and future directions; the future of clinical islet transplantation as a cure for diabetes. , 2008, Frontiers in bioscience : a journal and virtual library.

[16]  S. Bonner-Weir,et al.  Differentiation of Affinity-Purified Human Pancreatic Duct Cells to β-Cells , 2007, Diabetes.

[17]  L. Rosenberg,et al.  Prospects and Challenges for Islet Regeneration as a Treatment for Diabetes: A Review of Islet Neogenesis Associated Protein , 2007, Journal of diabetes science and technology.

[18]  R. Johns,et al.  Intramuscular Injection of Islet Neogenesis-Associated Protein Peptide Stimulates Pancreatic Islet Neogenesis in Healthy Dogs , 2007, Pancreas.

[19]  S. Bonner-Weir,et al.  Differentiation of affinity-purified human pancreatic duct cells to beta-cells. , 2007, Diabetes.

[20]  E. Kroon,et al.  Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells , 2006, Nature Biotechnology.

[21]  D. Harlan,et al.  Islet neogenesis associated protein transgenic mice are resistant to hyperglycemia induced by streptozotocin. , 2006, The Journal of endocrinology.

[22]  A. Boschero,et al.  INGAP-related pentadecapeptide: Its modulatory effect upon insulin secretion , 2005, Regulatory Peptides.

[23]  R. Sladek,et al.  Morphogenetic plasticity of adult human pancreatic islets of Langerhans , 2005, Cell Death and Differentiation.

[24]  J. Lakey,et al.  Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet {beta}-cells from pancreatic duct cells and an increase in functional {beta}-cell mass. , 2005, The Journal of clinical endocrinology and metabolism.

[25]  M. Prentki,et al.  A Pentadecapeptide Fragment of Islet Neogenesis-Associated Protein Increases Beta-Cell Mass and Reverses Diabetes in C57BL/6J Mice , 2004, Annals of surgery.

[26]  Yuval Dor,et al.  Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. , 2004, Nature.

[27]  J. Itskovitz‐Eldor,et al.  Insulin production by human embryonic stem cells. , 2001, Diabetes.

[28]  B. Portha,et al.  Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. , 2001, Diabetes.

[29]  R. McKay,et al.  Differentiation of Embryonic Stem Cells to Insulin-Secreting Structures Similar to Pancreatic Islets , 2001, Science.

[30]  S. Bonner-Weir,et al.  In vitro cultivation of human islets from expanded ductal tissue. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Reig,et al.  Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. , 2000, Diabetes.

[32]  X. Qin,et al.  Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters. , 1997, The Journal of clinical investigation.

[33]  A. Vinik,et al.  Induction of endocrine cell differentiation: a new approach to management of diabetes. , 1989, The Journal of laboratory and clinical medicine.

[34]  A. Vinik,et al.  Induction of Nesidioblastosis Will Reverse Diabetes in Syrian Golden Hamster , 1988, Diabetes.